Clinical Trial Update: Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression [Phase 2]

View source ↗

Summary

A Phase 2 trial of cariprazine in bipolar depression completed, with results on safety, tolerability, and efficacy posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: Forest Laboratories | Conditions: Depression, Bipolar | Phase 2 | Status: COMPLETED | Results posted: 2018-05-01